Bicocca Open Archive

Logo unimib boa
ROTA, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.744
AS - Asia 5.844
EU - Europa 5.332
SA - Sud America 880
AF - Africa 237
Continente sconosciuto - Info sul continente non disponibili 23
OC - Oceania 20
Totale 24.080
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.991
SG - Singapore 2.183
CN - Cina 1.419
IT - Italia 1.336
RU - Federazione Russa 741
DE - Germania 678
CA - Canada 676
HK - Hong Kong 666
SE - Svezia 650
VN - Vietnam 642
BR - Brasile 641
IE - Irlanda 474
UA - Ucraina 440
GB - Regno Unito 286
FR - Francia 220
IN - India 213
BD - Bangladesh 147
FI - Finlandia 140
ZA - Sudafrica 109
TR - Turchia 87
AR - Argentina 80
NL - Olanda 74
IQ - Iraq 64
AT - Austria 63
KR - Corea 63
DK - Danimarca 54
MX - Messico 49
JP - Giappone 47
PK - Pakistan 42
EC - Ecuador 40
CO - Colombia 36
ES - Italia 35
ID - Indonesia 34
PL - Polonia 33
SA - Arabia Saudita 30
MA - Marocco 27
VE - Venezuela 27
PH - Filippine 26
BE - Belgio 22
MY - Malesia 22
CL - Cile 21
EG - Egitto 18
IR - Iran 18
AE - Emirati Arabi Uniti 17
EU - Europa 16
KE - Kenya 15
ET - Etiopia 14
PY - Paraguay 14
TN - Tunisia 14
UZ - Uzbekistan 14
AU - Australia 13
DZ - Algeria 13
JO - Giordania 13
NP - Nepal 11
TH - Thailandia 11
AZ - Azerbaigian 10
CH - Svizzera 10
CZ - Repubblica Ceca 10
GR - Grecia 10
IL - Israele 10
PE - Perù 10
LB - Libano 9
RO - Romania 8
CR - Costa Rica 7
NO - Norvegia 7
JM - Giamaica 6
NZ - Nuova Zelanda 6
OM - Oman 6
PS - Palestinian Territory 6
TW - Taiwan 6
UY - Uruguay 6
BG - Bulgaria 5
BH - Bahrain 5
BO - Bolivia 5
MD - Moldavia 5
A1 - Anonimo 4
HU - Ungheria 4
KZ - Kazakistan 4
LT - Lituania 4
PT - Portogallo 4
RS - Serbia 4
SN - Senegal 4
ZM - Zambia 4
AO - Angola 3
HR - Croazia 3
KW - Kuwait 3
MN - Mongolia 3
MU - Mauritius 3
PR - Porto Rico 3
TT - Trinidad e Tobago 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BY - Bielorussia 2
GA - Gabon 2
GE - Georgia 2
KG - Kirghizistan 2
LV - Lettonia 2
NG - Nigeria 2
NI - Nicaragua 2
QA - Qatar 2
RE - Reunion 2
Totale 24.049
Salva come PNG Salva come JPEG
Città #
Singapore 1.266
Woodbridge 978
Ann Arbor 953
Ashburn 952
Houston 726
Fairfield 661
Hong Kong 650
Chandler 605
San Jose 587
Toronto 488
Jacksonville 451
Dublin 450
Dearborn 369
Milan 358
New York 347
Frankfurt am Main 319
Wilmington 315
Seattle 271
Cambridge 258
Santa Clara 254
Beijing 216
Princeton 201
Dallas 173
Chicago 154
The Dalles 154
Los Angeles 152
Hanoi 144
Ho Chi Minh City 139
Nanjing 138
Shanghai 115
Council Bluffs 98
Altamura 95
Lauterbourg 90
Lawrence 82
Lachine 81
Rome 72
São Paulo 71
Moscow 67
Buffalo 64
Cape Town 60
Hefei 59
Nanchang 59
Guangzhou 57
Dong Ket 55
Vienna 55
Columbus 54
San Diego 50
Orem 49
Helsinki 48
Shenyang 46
Boardman 44
Seoul 40
Andover 39
Hebei 37
Ottawa 37
Tianjin 34
Munich 33
Tokyo 31
Jinan 30
Jiaxing 28
Manchester 28
Changsha 27
Warsaw 27
Baghdad 26
Hangzhou 25
Boston 24
Da Nang 24
Zhengzhou 24
Lissone 23
London 22
Mountain View 22
Fremont 21
Haiphong 21
Washington 21
Bologna 20
Brooklyn 20
Istanbul 20
Johannesburg 20
Montreal 20
Chennai 19
Irvine 18
Newark 18
Phoenix 18
San Francisco 18
Dhaka 17
Mumbai 16
Nairobi 15
Rio de Janeiro 15
Salt Lake City 15
Brussels 14
Denver 14
Guayaquil 14
Huizen 14
Hải Dương 14
Ningbo 14
Norwalk 14
Nürnberg 14
Biên Hòa 13
Kunming 13
Lahore 13
Totale 15.264
Salva come PNG Salva come JPEG
Nome #
Continuous monitoring of cerebral blood flow (CBF) and cerebral temperature in neurocritical care unit 473
Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine 388
Value-based outcome indicators in the management of hepatocellular carcinoma: Clinical test in a large multicenter study (VBMH study) 364
Intracerebral hemorrhage in intensive care unit: early prognostication fallacies. A single center retrospective study 356
Alcohol consumption and site-specific cancer risk: A comprehensive dose-response meta-analysis 356
An Effective and Safe Strategy to Target Normothermia in Neurocritical Patients 340
Health related quality of life in chronic liver diseases 340
Trattamento con Sofosbuvir e Ribavirina nei pazienti hcv-positivi listati per il trapianto di fegato: un analisi di costo-efficacia 324
Generation and performance of value-based outcome indicators in liver disease: The multicenter V.B.M.H. study 317
Outcome indicators in liver cirrhosis: Application of value-based medicine in a large multicenter study (VBMH study) 315
High-Resolution Intracranial Pressure Burden and Outcome in Subarachnoid Hemorrhage 314
Organ donation after brain death in refractory cardiac arrest treated with extracorporeal CPR 312
P1169 : Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 304
Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 302
Outcome Indicators in Primary Sclerosing Cholangitis: Interim Analysis Of The Value-Based Medicine In Hepatology (VBMH) Study 300
A noninvasive index of atrial remodeling in patients with paroxysmal and persistent atrial fibrillation: a pilot study 299
The impact of liver disease on the health-related quality of life 298
Intracranial pressure monitor insertion in traumatic brain injury: a single center, retrospective decision process analysis 297
Measurement of clinical outcomes and quality of life indicators as a new value-based approach to liver cirrhosis management 291
A Comparison Between The Health-Related Quality Of Life Reported By The General Population And By Patients With Major Liver Diseases 290
Value-based outcome indicators in liver cirrhosis: validation in a large multicenter study (VBMH study) 289
P0811 : Sofosbuvir-based direct-acting antivirals treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis 288
Direct-acting antivirals combination for elderly patients with chronic hepatitis C: A cost-effectiveness analysis 288
Generation and Performance of Outcome Indicators in Liver Cirrhosis: The Value Based Medicine in Hepatology Study (V.B.M.H.) 286
Alcohol drinking and pancreatic cancer risk: a meta-analysis of the dose-risk relation 285
Characteristics of patients with Chronic Hepatitis C who have failed past treatment or who have never been treated: How much room left for Interferon? 283
Impatto dei farmaci anti virali ad azione diretta sulla cura dei pazienti con epatite C: un approccio di value-based medicine 281
A value-based approach to the management of patients with liver cirrhosis through the systematic measurement of clinical outcome and quality of life indicators 274
The Impact of Type of Liver Conditions on the Patients’ Health Related Quality of Life 272
Random-effects meta-regression models for studying nonlinear dose-response relationship, with an application to alcohol and esophageal squamous cell carcinoma 271
Health Related Quality of Life in the Major Liver Conditions 270
Difference in health related quality of life of chronic liver diseases and general population 270
Alcohol drinking and risk of renal cell carcinoma: results of a meta-analysis 268
Value-based approach to hepatocellular carcinoma: outcome indicators tested in a large multicenter study (VBMH study) 268
Single-Incision Versus Standard Multiple-Incision Laparoscopic Cholecystectomy: A Meta-analysis of Experimental and Observational Studies 267
Trajectories of early secondary insults after traumatic brain injury: a new approach to evaluate impact on outcome 265
Management of treatment-naïve chronic hepatitis C genotype 1 patients: A cost-effectiveness analysis of treatment options 263
External Ventricular and Lumbar Drain Device Infections in ICU Patients: A Prospective Multicenter Italian Study 261
Incidence of pain after craniotomy in children 260
Alcohol drinking and non-Hodgkin lymphoma risk: a systematic review and a meta-analysis 257
Alcohol drinking and laryngeal cancer: Overall and dose-risk relation - A systematic review and meta-analysis 256
Organ donation in cardiac arrest patients treated with extracorporeal CPR: A single centre observational study 256
Sofosbuvir-based all-oral treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis 254
Should new antiviral treatments be considered in elderly Chronic Hepatitis C patients? 252
Alcohol drinking and multiple myeloma risk - A systematic review and meta-analysis of the dose-risk relationship 252
PGI31 Health Care Indicators to Measure Quality of Care in Patients with Liver Diseases 251
Alcohol drinking and esophageal squamous cell carcinoma with focus on light-drinkers and never-smokers: A systematic review and meta-analysis 247
A prospective evaluation of short-term and long-term results from colonic stenting for palliation or as a bridge to elective operation versus immediate surgery for large-bowel obstruction 247
Should Sofosbuvir-Based All-Oral Treatment Be Considered In Elderly Chronic Hepatitis C Patients? 246
A meta-analysis on alcohol drinking and gastric cancer risk 245
Incidence of inhibitors to recombinant factor VIII products – A meta-analysis of 1,852 previously untreated patients 245
Alcohol drinking and colorectal cancer risk: an overall and dose-response meta-analysis of published studies 243
Alcohol drinking and epithelial ovarian cancer risk. A systematic review and meta-analysis 243
Applicazione della value-based medicine nella valutazione della cura dei pazienti affetti da epatite. 242
Alcohol consumption and lung cancer risk in never smokers: a meta-analysis 240
Meta-analysis on incidence of inhibitors in patients with haemophilia A treated with recombinant factor VIII products 236
PGI36 Relationship Between Clinical Severity and Health Related Quality of Life in Chronic Liver Diseases 235
A meta-analysis on alcohol drinking and esophageal and gastric cardia adenocarcinoma risk 234
Trajectories of early secondary insults correlate to outcomes of traumatic brain injury: results from a large, single centre, observational study 234
Factors influencing the decision to monitor intracranial pressure in traumatic brain injury. A large monocentric study 233
A meta-analysis of alcohol drinking and oral and pharyngeal cancers. Part 1: Overall results and dose-risk relation 232
Light alcohol drinking and cancer: a meta-analysis 231
Strong excess risk of pancreatic cancer for low frequency and duration of cigarette smoking: A comprehensive review and meta-analysis 231
A meta-analysis of alcohol drinking and oral and pharyngeal cancers. Part 2: Results by subsites 228
The Cost-Effectiveness Of Sofosbuvir And Ribavirin Treatment In Hcv-Infected Patients Listed For Liver Transplantation 227
Alcohol drinking and cutaneous melanoma risk: A systematic review and dose-risk meta-analysis 226
Management of chronic hepatitis C (Chc) genotype 1 treatment-naïve patients in an era of rising opportunities and costs: A cost-effectiveness analysis 223
Prospective multicentre cohort study evaluating the incidence of pain after craniotomy in children: first interim analysis. 223
A simulation study comparing performance of minimum P-value and Youden index as methods to find optimal cut-points of continuous variables 222
Donor safety in living donor liver donation: An Italian multicenter survey 222
Modelling body mass index and endometrial cancer risk in a pooled-analysis of three case-control studies 221
Re: light drinking has positive public health consequences 220
Is multifocality a prognostic factor in childhood hepatoblastoma? 218
Cost-effectiveness of Sofosbuvir plus Ledipasvir Antiviral Treatment for Elderly Patients with Chronic Hepatitis C Genotype 1 216
Alcohol consumption and prostate cancer risk: A meta-analysis of the dose-risk relation 215
Thromboembolic event rate in patients exposed to anti-inhibitor coagulant complex: a meta-analysis of 40-year published data 215
Management of Chronic hepatitis C (CHC) Genotype 1 treatment-naive patients in an era of rising opportunities and costs - A cost-effectiveness analysis of treatment options 212
A meta-analysis of alcohol consumption and the risk of brain tumours 208
A random-effects meta-regression model for studying nonlinear dose-response relationship 204
A meta-analysis on alcohol drinking and the risk of Hodgkin lymphoma 203
Incidence of Thrombo-Embolic Events in Relation to Activated Prothrombin Complex Concentrate Exposure: A Literature Meta-Analysis 201
Finding the optimal cut-point for Gaussian and Gamma distributed biomarkers 195
Cut-pont finding methods for continuous biomarkers 186
Dose-response relationship between cigarette smoking and site-specific cancer risk: Protocol for a systematic review with an original design combining umbrella and traditional reviews 183
Alcohol drinking and risk of leukemia-A systematic review and meta-analysis of the dose-risk relation 181
Cut-Point Finding Methods For Continuous Biomarkers In The Presence Of Binary And Censored Failure Time Outcome 178
Sofosbuvir and ribavirinin in HCV-infected patients listed for liver transplantation: A cost-effectiveness analysis 178
Optimal cut-point definition in biomarkers: The case of censored failure time outcome 178
Quantifying the Dose-Response Relationship Between Circulating Folate Concentrations and Colorectal Cancer in Cohort Studies: A Meta-Analysis Based on a Flexible Meta-Regression Model 176
Alcohol and liver cancer: a systematic review and meta-analysis of prospective studies 175
Is there a difference in inhibitor incidence with recombinant products? A meta-analysis of 2000 previously untreated patients 175
Cost-effectiveness of new direct-acting antivirals to prevent post-liver transplant recurrent hepatitis 175
Safety and Efficacy of Subcutaneous Hepatitis B Immunoprophylaxis using" on demand" Approach: A Single Center Experience 169
Coffee consumption and risk of fractures: A systematic review and dose-response meta-analysis 167
Safety and Efficacy of Subcutaneous Hepatitis B Immunoprophylaxis using “on demand” Approach: A Single Center Experience 163
Cut-point identification in biomarkers for a censored failure time outcome 163
Cut-point identification in biomarkers for a censored failure time outcome 154
Meta-Analysis on Incidence of Inhibitors in 1,945 Previously Untreated Patients Treated with Recombinant Factor VIII Products: Is There a Difference? 148
Does alcohol consumption increase the risk of cutaneous melanoma? Comments on a recent meta-analysis: reply from the authors 141
Totale 24.620
Salva come PNG Salva come JPEG
Categoria #
all - tutte 79.392
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.392
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021157 0 0 0 0 0 0 0 0 0 0 0 157
2021/2022954 40 79 109 98 33 90 29 78 50 84 71 193
2022/20232.189 232 687 171 198 134 338 18 144 178 7 64 18
2023/20241.591 52 69 52 89 174 520 273 75 94 18 16 159
2024/20253.163 227 363 185 127 286 134 164 134 372 448 226 497
2025/20268.229 803 358 586 703 1.009 443 1.078 417 703 787 798 544
Totale 24.620